RBSP3 is frequently altered in premalignant cervical lesions: Clinical and prognostic significance

Genes Chromosomes and Cancer

Volumn 49, Issue 2, 2010, Pages 155-170

  Mitra, Sraboni ^a   Indra, Dipanjana Mazumder ^a   Bhattacharya, Nilanjana ^a   Singh, Ratnesh K ^a,b   Basu, Partha S ^a   Mondal, Ranajit K ^a   Roy, Anup ^c   Zabarovsky, Eugene R ^d   Roychoudhury, Susanta ^e   Panda, Chinmay K ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b West Virginia University Eye Institute   (United States)

^c MEDICAL COLLEGE AND HOSPITAL   (India)

^d KAROLINSKA INSTITUTE   (Sweden)

^e INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; METHIONINE SULFOXIDE REDUCTASE A; PROTEIN MLH1; VIRUS DNA;

ADULT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; ITGA9 GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RBSP3 GENE; STAC GENE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; CARCINOMA IN SITU; CHROMOSOMES, HUMAN, PAIR 3; DNA, NEOPLASM; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROGNOSIS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 75149165803     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20726     Document Type: Article

References (50)

1. Allen DG, White DJ, Hutchins AM, Scurry JP, Tabrizi SN, Garland SM, Armes JE. 2000. Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer 83:1659-1663.
2. Anedchenko EA, Kiseleva NP, Dmitriev AA, Kiselev FL, Zabarovskii ER, Senchenko VN. 2007. Tumor suppressor gene RBSP3 in cervical carcinoma: Copy number and transcriptional level. Mol Biol (Mosk) 41:86-95 (in Russian).
3. Atkin NB. 1997. Cytogenetics of carcinoma of the cervix uteri: A review. Cancer Genet Cytogenet 95:33-39.
4. Bhattacharya N, Singh RK, Mondal S, Roy A, Mondal R, Roychowdhury S, Panda CK. 2004. Analysis of molecular alterations in chromosome 8 associated with the development of uterine cervical carcinoma of Indian patients. Gynecol Oncol 95:352-362.
5. Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE, D'Cruz CM, Chodosh LA. 2006. Hormoneinduced protection against mammary tumorigenesis is conserved in multiple rat strains and identi.es a core gene expression signature induced by pregnancy. Cancer Res 66:6421-6431.
6. Brinkman BMN. 2004. Splice variants as cancer biomarkers. Clin Biochem 37:584-594.
7. Chakrabarti S, Dasgupta S, Roy S, Bhar A, Sengupta A, Roy A, Ray K, Bhattacharyya NP, Roy B, Panda CK, Roychoudhury S. 2001. Microsatellite instability in squamous cell carcinoma of head and neck from the Indian patient population. Int J Cancer 92:555-561.
8. Ciavattini A, Piccioni M, Tranquilli AL, Filosa A, Pieramici T, Goteri G. 2005. Immunohistochemical expression of DNA mismatch repair (MMR) system proteins (hMLH1, hMSH2) in cervical preinvasive and invasive lesions. Pathol Res Pract 201:21-25.
9. Dasgupta S, Mukherjee N, Roy S, Roy A, Sengupta A, Roychowdhury S, Panda CK. 2002. Mapping of candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of an Indian patient population. Oral Oncol 38:6-15.
10. Dasgupta S, Chakraborty SB, Roy A, Roychowdhury S, Panda CK. 2003. Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients. Mol Pathol 56:263-269.
11. Giarnieri E, Mancini R, Pisani T, Alderisio M, Vecchione A. 2000. Msh2, Mlh1, Fhit, p53, Bcl-2 and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix. Clin Cancer Res 6:3600-3606.
12. Grigienė R, Valuckas KP, Aleknavičius E, Kurtinaitis J, Letautienė SR. 2007. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone. BMC Cancer 7:234-243.
13. Hakkinen L, Kainilainen T, Salo T, Grenman R, Larjava H. 1999. Expression of integrin alpha9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma. Oral Dis 5:210-217.
14. Hampton GM, Larson AA, Baergen RN, Sommers RL, Kern S, Cavenee WK. 1996. Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: Subregional mapping of chromosome 4 in cervical carcinoma. Proc Natl Acad Sci USA 93:6704-6709.
15. Harris CP, Lu XY, Narayan G, Singh B, Murty VV, Rao PH. 2003. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer 36:233-241.
16. Heselmeyer K, Schröck E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T. 1996. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93:479-484.
17. Hu X, Guo Z, Pang T, Li Q, Afink G, Ponten J. 2000. Immunohistochemical and DNA sequencing analysis on human mismatch repair gene MLH1 in cervical squamous cell carcinoma with LOH of this gene. Anticancer Res 20:171-175.
18. Ichimura K, Bolin MB, Goike HM, Schmidt EE, Moshref A, Collins VP. 2000. Deregulation of p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res 60:417-424.
19. Kanaya T, Kyo S, Maida Y, Yatabe N, Tanaka M, Nakamura M, Inoue M. 2003. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers. Oncogene 22:2352-2360.
20. Kashuba VI, Gizatullin RZ, Protopopov AI, Li J, Vorobieva NV, Fedorova L, Zabarovska VI, Muravenko OV, Kost-Alimova M, Domninsky DA, Kiss C, Allikmets R, Zakharyev VM, Braga EA, Sumegi J, Lerman M, Wahlestedt C, Zelenin AV, Sheer D, Winberg G, Grafodatsky A, Kisselev LL, Klein G, Zabarovsky ER. 1999. Analysis of NotI linking clones isolated from human chromosome 3 specific libraries. Gene 239:259-271.
21. Kashuba VI, Li J, Wang F, Senchenko VN, Protopopov A, Malyukove A, Kutsenko AS, Kadyrova E, Zabarovska VI, Muravenko OV, Zelenin AV, Kisselev LL, Kuzmin I, Minna JD, Winberg G, Ernberg I, Braga E, Lerman MI, Klein G, Zabarovsky ER. 2004. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. Proc Natl Acad Sci USA 101:4906-4911.
22. Kekeeva TV, Zhevlova AI, Podistov YuI, Solov'eva YuV, Zaletaev DV, Nemtsova MV. 2006. Aberrant methylation of tumor suppressor genes and allelic imbalance in cervical intraepithelial neoplasia. Mol Biol 40:194-199.
23. Kim JW, Lee CG, Han SM, Kim KS, Kim JO, Lee JM, Kim IK, Namkoong SE. 1997. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection. Gynecol Oncol 67:215-221.
24. Koopman M, Kortman GA, Mekenkamp L, Ligtenberg MJL, Hoogerbrugge N, Antonini NF, Punt CJA, van Krieken JHJM. 2009. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Br J Cancer 100:266-273.
25. Larson AA, Kern S, Curtiss S, Gordon R, Cavenee WK, Hampton GM. 1997. High resolution analysis of chromosome 3p alterations in cervical carcinoma. Cancer Res 57:4082-4090.
26. Lazo PA. 1999. The molecular genetics of cervical carcinoma. Br J Cancer 80:2008-2016.
27. JL, Fei Q, Yu J, Zhang HY, Wang P, Zhu JD. 2004. Correlation between methylation profile of promoter cpg islands of seven metastasis associated genes and their expression states in six cell lines of liver origin. Ai Zheng 23:985-991.
28. Lima EM, Leal MF, Mde ACS, Burbano RR, Assumpção PP, Bello MJ, Rey JA, Lima FF, Casartelli C. 2008. DNA mismatch repair gene methylation in gastric cancer in individuals from northern Brazil. Biocell 32:237-243.
29. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
30. Loginov VI, Maliukova AV, Seregin IuA, Khodyrev DS, Kazubskaia TP, Ermilova VD, Gar'kavtseva RF, Kiselev LL, Zabarovskii ER, Braga EA. 2004. Methylation of the promoter region of the RASSF1A candidate tumor suppressor gene in primary epithelial tumors. Mol Biol (Mosk) 38:654-667.
31. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. 1994. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA 91:9871-9875.
32. Mitra AB, Murty VVVS, Li RG, Pratap M, Luthra UK, Chaganti RSK. 1994. Allelotype analysis of cervical carcinoma. Cancer Res 54:4481-4487.
33. Miyakoda M, Nakahata K, Suzuki K, Kodama S, Watanabe M. 2002. Heat-induced G1 arrest is dependent on p53 function but not on RB dephosphorylation. Biochem Biophys Res Commun 266:377-381.
34. Mullokandov MR, Kholodilov NG, Atkin NB, Burk RD, Johnson AB, Klinger HP. 1996. Genomic alterations in cervical carcinoma: Losses of chromosome heterozygosity and human papilloma virus tumor status. Cancer Res 56:197-205.
35. Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FF, Villella J, Schneider A, Terry MB, Mansukhani M, Murty VV. 2003. Frequent promoter methylation of CDH1, DAPK, RARb, and HIC1 genes in carcinoma of cervix uteri: Its relationship to clinical outcome. Mol Cancer 2:24-35.
36. Perrone F, Suardi S, Pastore E, Casieri P, Orsenigo M, Caramuta S, Dagrada G, Losa M, Licitra L, Bossi P, Sraurengo S, Oggionni M, Locati L, Cantu G, Squadrelli M, Carbone A, Pierotti M, Pilotti S. 2006. Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma. Clin Cancer Res 12:6643-6651.
37. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; http://www.scbt.com.
38. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3:1101-1108.
39. Sen U, Sankaranarayanan R, Mandal S, Ramanakumar AV, Parkin DM, Siddiqi M. 2002. Cancer patterns in eastern India: The first report of the kolkata cancer registry. Int J Cancer 100:86-91.
40. SenchenkoV, Liu J, Braga E, Lerman MI, Klein G, Zabarovsky ER. 2003. Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas. Oncogene 22:2984-2992.
41. Silins I, Avall-Lundqvist E, Tadesse A, Jansen KU, Stendahl U, Lenner P, Zumbach K, Pawlita M, Dillner J, Frankendal B. 2002. Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients. Gynecol Oncol 85:333-338.
42. Singh RK, Dasgupta S, Bhattacharya N, Chunder N, Mondal R, Roy A, Mandal S, Roychowdhury S, Panda CK. 2005. Deletion in chromosome 11 and Bcl-1/CyclinD1 alterations are independently associated with the development of uterine cervical carcinoma. J Cancer Res Clin Oncol 131:395-406.
43. Singh RK, Indra D, Mitra S, Mondal RK, Basu PS, Roy A, Roychowdhury S, Panda CK. 2007. Deletions in chromosome 4 differentially associated with the development of cervical cancer: Evidence of SLIT2 as a candidate tumor suppressor gene. Hum Genet 122:71-81.
44. Sinha S, Singh RK, Alam N, Roy A, Roychoudhury S, Panda CK. 2008. Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: Clinical and prognostic significance. Cancer Sci 99:1984-1991.
45. Slattery M, Overall JC, Jr., Abbott TM, French TK, Robison M, Gardner J. 1989. Sexual activity contraception, genital infections and cervical cancer: Support for a sexually transmitted disease hypothesis. Am J Epidemiol 130:248-259.
46. Sulimova GE, Rakhmanaliev ER, Klimov EA, Kompaniytsev AA, Udina IG, Zabarovsky ER, Kisselev LL. 2005. NotI sequence tagged sites as markers of genes on human chromosome 3. Mol Biol 39:593-607.
47. Suzuki H, Kawai J, Taga C, Yaoi T, Hara A, Hirose K, Hayashizaki Y, Watanabe S. 1996. Stac, a neuron specific protein with cysteine-rich and SH3 domains. Biochem Biophys Res Commun 229:902-909.
48. Vlahakis NE, Young BA, Atakilit A, Sheppard D. 2005. The lymphangiogenic vascular endothelial growth factors VEGF-C and D are ligands for the integrin α9b1. J Biol Chem 280:4544-4552.
49. Widschwendter A, Gattringer C, Ivarsson L, Fiegl H, Schneitter A, Ramoni A, Muller HM, Wiedemair A, Jerabek S, Muller-Holzner E, Goebel G, Marth C, Widschwendter M. 2004. Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors. Clin Cancer Res 10:3396-3400.
50. zur Hausen H. 2000. Papilloma virus causing cancer: Evasion from host cell control in early events in carcinogenesis. J Natl Cancer Inst 91:690-698.